Growth Patterns of HIV Infected Indian Children in Response to ART: A Clinic Based Cohort Study
- 135 Downloads
To describe catch-up growth after antiretroviral therapy (ART) initiation among children living with human immunodeficiency virus (CLHIV), attending a private clinic in India.
This is a retrospective analysis of data of CLHIV attending Prayas clinic, Pune, India. Height and weight z scores (HAZ, WAZ) were calculated using WHO growth charts. Catch-up growth post-ART was assessed using a mixed method model in cases where baseline and at least one subsequent follow-up HAZ/WAZ were available. STATA 12 was used for statistical analysis.
During 1998 to 2011, 466 children were enrolled (201 girls and 265 boys; median age = 7 y). A total of 302 children were ever started on ART; of which 73 and 76 children were included for analysis for catch up growth in WAZ and HAZ respectively. Median WAZ and HAZ increased from −2.14 to −1.34 (p = 0.007) and −2.42 to −1.94 (p = 0.34), respectively, 3 y post ART. Multivariable analysis using mixed model (adjusted for gender, guardianship, baseline age, baseline WAZ/HAZ, baseline and time varying WHO clinical stage) showed gains in WAZ (coef = 0.2, 95 % CI: −0.06 to 0.46) and HAZ (coef = 0.49, 95 % CI: 0.21 to 0.77) with time on ART. Lower baseline WAZ/HAZ and older age were associated with impaired catch-up growth. Children staying in institutions and with baseline advanced clinical stage showed higher gain in WAZ.
The prevalence of stunting and underweight was high at ART initiation. Sustained catch-up growth was seen with ART. The study highlights the benefit of early ART in achieving normal growth in CLHIV.
KeywordsHIV/AIDS HIV infected children Anti-retroviral therapy Catch up growth Growth failure
The authors thank the entire staff of the Prayas clinic for their efforts in maintaining the data which made this analysis possible.
RP had major contributions to conceptualization of the study, data cleaning and analysis and writing the paper. TD helped in data cleaning and analysis. BM and RM participated in study design and statistical analysis. PE and VK provided valuable inputs in refining the study design, and review of the manuscript. All authors read and approved the final manuscript. VK will act as guarantor for this paper.
Conflict of Interest
Source of Funding
The study was supported by Award Number D43TW006793 from the Fogarty International Center. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Fogarty International Center or the National Institutes of Health.
- 1.Newell ML, Borja MC, Peckham C; European Collaborative Study. Height, weight, and growth in children born to mothers with HIV-1 infection in Europe. Pediatrics. 2003;111:e52–60.Google Scholar
- 3.Ram M, Gupte N, Nayak U, Kinikar AA, Khandave M, Shankar AV, et al; SWEN India and BJMC-JHU Clinical Trials Study Team. Growth patterns among HIV-exposed infants receiving nevirapine prophylaxis in Pune, India. BMC Infect Dis. 2012;12:282.Google Scholar
- 4.Collins IJ, Jourdain G, Hansudewechakul R, Kanjanavanit S, Hongsiriwon S, Ngampiyasakul C, et al; Program for HIV Prevention and Treatment Study Team. Long-term survival of HIV-infected children receiving antiretroviral therapy in Thailand: a 5-year observational cohort study. Clin Infect Dis. 2010;51:1449–57.Google Scholar
- 9.Kekitiinwa A, Lee KJ, Walker AS, Maganda A, Doerholt K, Kitaka SB, et al. Differences in factors associated with initial growth, CD4, and viral load responses to ART in HIV-infected children in Kampala, Uganda, and the United Kingdom/Ireland. J Acquir Immune Defic Syndr. 2008;49:384–92.CrossRefPubMedGoogle Scholar
- 12.Department of AIDS control (NACO). Annual Report 2012–13.Google Scholar
- 18.WHO. Antiretroviral therapy of HIV infection in infants and children in resource-limited settings: towards universal access. 2006.Google Scholar
- 19.WHO. WHO Anthro (version 3.2.2, January 2011) and macros. 2012 [cited 2012 July 20]; Available from: http://www.who.int/childgrowth/software/en/.
- 20.WHO. Growth reference 5–19 years. 2012 [cited 2012 July 20]; Available from: http://www.who.int/growthref/tools/en/.
- 21.International Institute for Population Sciences (IIPS) and Macro International. National Family Health Survey (NFHS-3) 2005–06: India. Mumbai: IIPS; 2007.Google Scholar
- 23.Davies MA, Keiser O, Technau K, Eley B, Rabie H, van Cutsem G, et al; International Epidemiologic Databases to Evaluate AIDS Southern Africa (IeDEA-SA) Collaboration. Outcomes of the South African national antiretroviral treatment programme for children: the IeDEA Southern Africa collaboration. S Afr Med J. 2009;99:730–7.Google Scholar
- 25.Puthanakit T, Saphonn V, Ananworanich J, Kosalaraksa P, Hansudewechakul R, Vibol U, et al. Early versus deferred antiretroviral therapy for children older than 1 year infected with HIV (PREDICT): a multicentre, randomised, open-label trial. Lancet Infect Dis. 2012;12:933–41.CrossRefPubMedCentralPubMedGoogle Scholar
- 26.Anonymous. Natural history of vertically acquired human immunodeficiency virus-1 infection. The European Collaborative Study. Pediatrics. 1994;94:815–9.Google Scholar
- 29.World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. Geneva: WHO; 2013.Google Scholar